The technical aspects of bioassay strategies are essential as ever while the biotech industry launches new biologics including modified proteins, DNA, RNA and cell-based therapeutics…
Speakers
F. Hoffmann - La Roche Ltd.
Boehringer Ingelheim Pharma GmbH & Co. KG
Charles River Laboratories
Sciensano (Belgian Institute for Health